Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245


SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.

Bourgo RJ, Siddiqui H, Fox S, Solomon D, Sansam CG, Yaniv M, Muchardt C, Metzger D, Chambon P, Roberts CW, Knudsen ES.

Mol Biol Cell. 2009 Jul;20(14):3192-9. doi: 10.1091/mbc.E08-12-1224. Epub 2009 May 20.


The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes.

de la Serna IL, Ohkawa Y, Higashi C, Dutta C, Osias J, Kommajosyula N, Tachibana T, Imbalzano AN.

J Biol Chem. 2006 Jul 21;281(29):20233-41. Epub 2006 Apr 28.


MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes.

de la Serna IL, Roy K, Carlson KA, Imbalzano AN.

J Biol Chem. 2001 Nov 2;276(44):41486-91. Epub 2001 Aug 24.


Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex.

Mizutani T, Ito T, Nishina M, Yamamichi N, Watanabe A, Iba H.

J Biol Chem. 2002 May 3;277(18):15859-64. Epub 2002 Feb 15.


Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities.

Gunduz E, Gunduz M, Nagatsuka H, Beder L, Demircan K, Tamamura R, Hatipoglu OF, Mahmut N, Katase N, Naomoto Y, Nagai N.

Med Hypotheses. 2006;67(6):1313-6. Epub 2006 Jul 5.


SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B.

Gunawardena RW, Fox SR, Siddiqui H, Knudsen ES.

J Biol Chem. 2007 Jul 13;282(28):20116-23. Epub 2007 May 17.


Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.

Shen W, Xu C, Huang W, Zhang J, Carlson JE, Tu X, Wu J, Shi Y.

Biochemistry. 2007 Feb 27;46(8):2100-10. Epub 2007 Feb 3.


Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme.

Hill DA, Chiosea S, Jamaluddin S, Roy K, Fischer AH, Boyd DD, Nickerson JA, Imbalzano AN.

J Cell Sci. 2004 Nov 15;117(Pt 24):5847-54.


SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.

Cohet N, Stewart KM, Mudhasani R, Asirvatham AJ, Mallappa C, Imbalzano KM, Weaver VM, Imbalzano AN, Nickerson JA.

J Cell Physiol. 2010 Jun;223(3):667-78. doi: 10.1002/jcp.22072.


Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response.

Ramirez-Carrozzi VR, Nazarian AA, Li CC, Gore SL, Sridharan R, Imbalzano AN, Smale ST.

Genes Dev. 2006 Feb 1;20(3):282-96.


Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.

Hurlstone AF, Olave IA, Barker N, van Noort M, Clevers H.

Biochem J. 2002 May 15;364(Pt 1):255-64.


N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons.

Kazantseva A, Sepp M, Kazantseva J, Sadam H, Pruunsild P, Timmusk T, Neuman T, Palm K.

J Neurochem. 2009 May;109(3):807-18. doi: 10.1111/j.1471-4159.2009.06005.x. Epub 2009 Feb 20.


Expression of chromatin remodeling factors during neural differentiation.

Machida Y, Murai K, Miyake K, Iijima S.

J Biochem. 2001 Jan;129(1):43-9.


SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.

Banine F, Bartlett C, Gunawardena R, Muchardt C, Yaniv M, Knudsen ES, Weissman BE, Sherman LS.

Cancer Res. 2005 May 1;65(9):3542-7.


Repression of GR-mediated expression of the tryptophan oxygenase gene by the SWI/SNF complex during liver development.

Inayoshi Y, Kaneoka H, Machida Y, Terajima M, Dohda T, Miyake K, Iijima S.

J Biochem. 2005 Oct;138(4):457-65.


Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.

Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B.

Prostate. 2007 Feb 1;67(2):203-13.


Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.

Hoffman GR, Rahal R, Buxton F, Xiang K, McAllister G, Frias E, Bagdasarian L, Huber J, Lindeman A, Chen D, Romero R, Ramadan N, Phadke T, Haas K, Jaskelioff M, Wilson BG, Meyer MJ, Saenz-Vash V, Zhai H, Myer VE, Porter JA, Keen N, McLaughlin ME, Mickanin C, Roberts CW, Stegmeier F, Jagani Z.

Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3128-33. doi: 10.1073/pnas.1316793111. Epub 2014 Feb 11.


Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.

Wang X, Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PT, Roberts CW.

Cancer Res. 2009 Oct 15;69(20):8094-101. doi: 10.1158/0008-5472.CAN-09-0733. Epub 2009 Sep 29.

Supplemental Content

Support Center